薬物スクリーニング市場：製品タイプ別、サンプルタイプ別、エンドユーザー別-2025-2030年の世界予測

薬物スクリーニング市場は、2023年に86億6,000万米ドルと評価され、2024年には98億9,000万米ドルに達すると予測され、CAGR 14.42%で成長し、2030年には222億5,000万米ドルに達すると予測されています。

薬物スクリーニング市場は、ヘルスケアおよび法執行セクターの重要な構成要素であり、職場の薬物検査、医療スクリーニング、法執行、スポーツのドーピング検査など、幅広い用途に対応しています。薬物スクリーニングの必要性は、薬物乱用の増加や、薬物中毒が公衆衛生や職場の安全に与える重大な影響から生じています。高感度かつ迅速な検査法の開発などの技術開拓が適用範囲を拡大し、市場成長をさらに後押ししています。北米や欧州のような先進地域では、さまざまな分野での薬物検査を義務付ける厳しい規制があり、その結果、最終用途の範囲が広がっていることも需要を後押ししています。成長に影響を与える主な要因としては、薬物検査の利点に関する意識の高まり、技術の進歩、ヘルスケアインフラの改善による新興市場での薬物検査量の増加などが挙げられます。しかし、プライバシーの問題、偽陽性の可能性、高度な検査方法の高コストといった課題は、市場の成長を阻害する可能性があります。こうしたハードルにもかかわらず、新たなビジネスチャンスは、利便性と効率性を提供する革新的な非侵襲的検査技術やモバイル検査プラットフォームの開発から生まれています。企業は、効率的で即時性の高い検査結果を求める需要の高まりに対応するため、携帯可能でユーザーフレンドリーな検査キットの研究や技術革新、デジタル報告システムとの統合に注力すべきです。さらに、薬物乱用の問題が高まっている成長経済圏でサービスを拡大することは、実行可能な成長経路を提示します。市場はダイナミックで、積極的な競合と絶え間ない技術アップグレードを特徴とし、常に適応する必要があります。規制基準や多額の設備投資の必要性による参入障壁も課題となり得る。したがって、企業は複雑な市場を効果的に切り抜けるために、規制に関する専門知識とイノベーション能力を高めることを優先すべきです。

市場力学：急速に進化する薬物スクリーニング市場の主要市場インサイトを公開

薬物スクリーニング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 娯楽用薬物および処方薬物の誤用の世界的急増
  • 職場の安全性とコンプライアンスの向上
  • 薬物検査を義務付ける政府による規制と政策
• 市場抑制要因
  • 薬物スクリーニングの結果が操作される可能性
• 市場機会
  • 革新的な薬物スクリーニング技術とキットの開発
  • モバイルおよびオンサイト薬物検査サービスへの需要の高まり
• 市場の課題
  • 各国における薬物スクリーニングの標準的な規制枠組みの欠如

ポーターのファイブフォース：薬物スクリーニング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：薬物スクリーニング市場における外部からの影響の把握

外部マクロ環境要因は、薬物スクリーニング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：薬物スクリーニング市場における競合情勢の把握

薬物スクリーニング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス：薬物スクリーニング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、薬物スクリーニング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：薬物スクリーニング市場における成功への道筋を描く

薬物スクリーニング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で娯楽目的および処方薬の乱用が急増
    • 職場の安全性とコンプライアンスの向上
    • 薬物検査を義務付ける政府による規制や組織の方針
  • 抑制要因
    • 薬物スクリーニングの結果を操作する可能性
  • 機会
    • 革新的な薬物スクリーニング技術とキットの開発
    • モバイルおよびオンサイトの薬物検査サービスに対する需要の増加
  • 課題
    • 経済全体にわたる薬物スクリーニングの標準的な規制枠組みの欠如
• 市場セグメンテーション分析
  • 製品：非侵襲的で迅速な結果を提供する口腔液検査装置の利用が急増
  • エンドユーザー：薬物治療センターにおける薬物スクリーニングの重要な利用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 薬物スクリーニング市場：製品別

• 消耗品
  • アッセイキット
  • キャリブレーターとコントロール
  • サンプル収集チューブ
• 機器
  • 分析機器
    • アルコール検知器
    • 燃料電池アルコール検知器
    • 半導体アルコール検知器
    • クロマトグラフィー機器
    • 免疫測定分析装置
  • 迅速検査装置
    • 口腔液検査装置
    • 尿検査装置
    • ディップカード
    • 薬物検査カセット
    • 薬物検査カップ
• サービス

第7章 薬物スクリーニング市場：サンプルタイプ別

• 呼気サンプル
• 毛髪サンプル
• 口腔液サンプル
• 尿サンプル

第8章 薬物スクリーニング市場：エンドユーザー別

• 刑事司法制度と法執行機関
• 薬物検査研究所
• 薬物治療センター
• 病院
• 個人ユーザー
• 疼痛管理センター
• 学校と大学
• 職場

第9章 南北アメリカの薬物スクリーニング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の薬物スクリーニング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの薬物スクリーニング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 革新的なパートナーシップが仮想薬物スクリーニングプラットフォームを立ち上げ
  • Accurate Backgroundの高度な薬物および健康スクリーニングサービスの開始
  • bioXcelerateがAIを活用したスクリーニングツールで創薬に革命を起こす
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AccuSourceHR, Inc.
• ACM Global Laboratories
• Alfa Scientific Designs, Inc.
• Bio-Rad Laboratories, Inc.
• Clinical Reference Laboratory, Inc.
• Cordant Health Solutions
• Danaher Corporation
• Dragerwerk AG & Co. KGaA
• F. Hoffmann-La Roche Ltd.
• Intoximeters, Inc.
• Laboratory Corporation of America Holdings
• Lifeloc Technologies, Inc.
• Merck KGaA
• Omega Laboratories, Inc. by Juno Pharmaceuticals Corp.
• OraSure Technologies, Inc.
• Pfizer Inc.
• Premier Biotech, LLC
• Psychemedics Corporation
• Quest Diagnostics Incorporated
• Sartorius AG
• Securetec Detektions-Systeme AG
• Shimadzu Corporation
• Siemens AG
• Thermo Fisher Scientific Inc.
• United States Drug Testing Laboratories, Inc.

LIST OF FIGURES

• FIGURE 1. DRUG SCREENING MARKET RESEARCH PROCESS
• FIGURE 2. DRUG SCREENING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG SCREENING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG SCREENING MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DRUG SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. CANADA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 76. CANADA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 77. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 78. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 79. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 80. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. CHINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 123. CHINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 124. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 125. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 126. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. INDIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 132. INDIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 133. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 134. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 135. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 136. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 137. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 141. INDONESIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 142. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 146. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. JAPAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 150. JAPAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 151. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 155. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. MALAYSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 159. MALAYSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 160. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 162. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 165. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. PHILIPPINES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 168. PHILIPPINES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 169. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 171. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SINGAPORE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 177. SINGAPORE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 178. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 180. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 181. SINGAPORE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 182. SINGAPORE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 183. SINGAPORE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 186. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 189. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 191. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 192. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. TAIWAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. TAIWAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 195. TAIWAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 196. TAIWAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 198. TAIWAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. TAIWAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 200. TAIWAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 201. TAIWAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. THAILAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. THAILAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 204. THAILAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 205. THAILAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 207. THAILAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. THAILAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 209. THAILAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 210. THAILAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. VIETNAM DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. VIETNAM DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 213. VIETNAM DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 214. VIETNAM DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 216. VIETNAM DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 217. VIETNAM DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 218. VIETNAM DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 219. VIETNAM DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 230. DENMARK DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. DENMARK DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 232. DENMARK DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 233. DENMARK DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 235. DENMARK DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 236. DENMARK DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 237. DENMARK DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 238. DENMARK DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 239. EGYPT DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. EGYPT DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 241. EGYPT DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 242. EGYPT DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 244. EGYPT DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 245. EGYPT DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 246. EGYPT DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 247. EGYPT DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 249. FINLAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 251. FINLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 253. FINLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 254. FINLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 255. FINLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 256. FINLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 258. FRANCE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 260. FRANCE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 262. FRANCE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 263. FRANCE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 264. FRANCE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 265. FRANCE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 267. GERMANY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 269. GERMANY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 271. GERMANY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 272. GERMANY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 273. GERMANY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 274. GERMANY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 275. ISRAEL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 276. ISRAEL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 277. ISRAEL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 278. ISRAEL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 280. ISRAEL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 281. ISRAEL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 282. ISRAEL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 283. ISRAEL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. ITALY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 285. ITALY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 286. ITALY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 287. ITALY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 288. ITALY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 289. ITALY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 290. ITALY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 291. ITALY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 292. ITALY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 293. NETHERLANDS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 294. NETHERLANDS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 295. NETHERLANDS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 296. NETHERLANDS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 297. NETHERLANDS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 298. NETHERLANDS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 299. NETHERLANDS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 300. NETHERLANDS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 301. NETHERLANDS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 302. NIGERIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 303. NIGERIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 304. NIGERIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 305. NIGERIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 306. NIGERIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 307. NIGERIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 308. NIGERIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 309. NIGERIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 310. NIGERIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 311. NORWAY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 312. NORWAY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 313. NORWAY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 314. NORWAY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 315. NORWAY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 316. NORWAY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 317. NORWAY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 318. NORWAY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 319. NORWAY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 320. POLAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 321. POLAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 322. POLAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 323. POLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 324. POLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 325. POLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 326. POLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 327. POLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 328. POLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 329. QATAR DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 330. QATAR DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 331. QATAR DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 332. QATAR DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 333. QATAR DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 334. QATAR DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 335. QATAR DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 336. QATAR DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 337. QATAR DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 338. RUSSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 339. RUSSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 340. RUSSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 341. RUSSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 342. RUSSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 343. RUSSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 344. RUSSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 345. RUSSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 346. RUSSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 347. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 348. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 349. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 350. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 351. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
• TABLE 352. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 353. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
• TABLE 354. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 355. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 356. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 357. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 358. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 359. SOUTH AFRICA DRUG SCREENING MARKET SI

The Drug Screening Market was valued at USD 8.66 billion in 2023, expected to reach USD 9.89 billion in 2024, and is projected to grow at a CAGR of 14.42%, to USD 22.25 billion by 2030.

The drug screening market is a crucial component of the healthcare and law enforcement sectors, serving a wide range of applications such as workplace drug testing, medical screening, law enforcement, and sports doping tests. The necessity of drug screening arises from the increasing incidence of substance abuse and the significant impact of drug addiction on public health and workplace safety. Advances in technology, such as the development of highly sensitive and rapid testing methods, have expanded the application scope, further driving market growth. The demand is bolstered by stringent regulations in developed regions like North America and Europe, which mandate drug testing for various sectors, thus broadening the end-use scope. Key influencing growth factors include rising awareness about drug testing benefits, technological advancements, and the increasing volume of drug testing in emerging markets due to improved healthcare infrastructure. However, challenges such as privacy concerns, potential false positives, and the high cost of advanced testing methods can impede market growth. Despite these hurdles, emerging opportunities stem from the development of innovative non-invasive testing technologies and mobile testing platforms, which offer convenience and efficiency. Businesses should focus on research and innovation in portable and user-friendly testing kits, as well as integration with digital reporting systems, to capitalize on the increased demand for efficient and immediate results. Additionally, expanding services in growing economies with rising issues of drug abuse presents a viable growth path. The market is dynamic, characterized by aggressive competition and continuous technological upgrades, necessitating constant adaptation. Entry barriers due to regulatory standards and the need for significant capital investment can also pose challenges. Therefore, companies should prioritize building strong regulatory expertise and innovation capabilities to navigate market complexities effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Screening Market

The Drug Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surge in both recreational and prescription drug misuse globally
  • Increased safety and compliance in workplaces
  • Regulations by governments and organizational policies mandating drug testing
• Market Restraints
  • Possibility of manipulation of drug screening results
• Market Opportunities
  • Development of innovative drug screening technologies and kits
  • Growing demand for mobile and on-site drug testing services
• Market Challenges
  • Lack of standard regulatory framework for drug screening across economies

Porter's Five Forces: A Strategic Tool for Navigating the Drug Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Screening Market

A detailed market share analysis in the Drug Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Screening Market

A strategic analysis of the Drug Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuSourceHR, Inc., ACM Global Laboratories, Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Danaher Corporation, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Intoximeters, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc., Merck KGaA, Omega Laboratories, Inc. by Juno Pharmaceuticals Corp., OraSure Technologies, Inc., Pfizer Inc., Premier Biotech, LLC, Psychemedics Corporation, Quest Diagnostics Incorporated, Sartorius AG, Securetec Detektions-Systeme AG, Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Inc., and United States Drug Testing Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Calibrators & Controls, and Sample Collection Tubes. The Instruments is further studied across Analytical Instruments and Rapid Testing Devices. The Analytical Instruments is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Breathalyzers is further studied across Fuel-Cell Breathalyzers and Semiconductor Breathalyzers. The Rapid Testing Devices is further studied across Oral Fluid Testing Devices and Urine Testing Devices. The Urine Testing Devices is further studied across Dip Cards, Drug Testing Cassettes, and Drug Testing Cups.
• Based on Sample Type, market is studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples.
• Based on End User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Schools & Colleges, and Workplaces.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surge in both recreational and prescription drug misuse globally
    • 5.1.1.2. Increased safety and compliance in workplaces
    • 5.1.1.3. Regulations by governments and organizational policies mandating drug testing
  • 5.1.2. Restraints
    • 5.1.2.1. Possibility of manipulation of drug screening results
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of innovative drug screening technologies and kits
    • 5.1.3.2. Growing demand for mobile and on-site drug testing services
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standard regulatory framework for drug screening across economies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Proliferating utilization of oral fluid testing devices providing non-invasive quick results
  • 5.2.2. End User: Significant utilization of the drug screening in the drug treatment centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Screening Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Assay Kits
  • 6.2.2. Calibrators & Controls
  • 6.2.3. Sample Collection Tubes
• 6.3. Instruments
  • 6.3.1. Analytical Instruments
    • 6.3.1.1. Breathalyzers
    • 6.3.1.1.1. Fuel-Cell Breathalyzers
    • 6.3.1.1.2. Semiconductor Breathalyzers
    • 6.3.1.2. Chromatography Instruments
    • 6.3.1.3. Immunoassay Analyzers
  • 6.3.2. Rapid Testing Devices
    • 6.3.2.1. Oral Fluid Testing Devices
    • 6.3.2.2. Urine Testing Devices
    • 6.3.2.2.1. Dip Cards
    • 6.3.2.2.2. Drug Testing Cassettes
    • 6.3.2.2.3. Drug Testing Cups
• 6.4. Services

7. Drug Screening Market, by Sample Type

• 7.1. Introduction
• 7.2. Breath Samples
• 7.3. Hair Samples
• 7.4. Oral Fluid Samples
• 7.5. Urine Samples

8. Drug Screening Market, by End User

• 8.1. Introduction
• 8.2. Criminal Justice Systems & Law Enforcement Agencies
• 8.3. Drug Testing Laboratories
• 8.4. Drug Treatment Centers
• 8.5. Hospitals
• 8.6. Individual Users
• 8.7. Pain Management Centers
• 8.8. Schools & Colleges
• 8.9. Workplaces

9. Americas Drug Screening Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Screening Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Screening Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Innovative Partnership Launches Virtual Drug Screening Platform
  • 12.3.2. Launch of Accurate Background's Advanced Drug and Health Screening Services
  • 12.3.3. bioXcelerate Revolutionizes Drug Discovery with AI-Powered Screening Tool
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AccuSourceHR, Inc.
• 3. ACM Global Laboratories
• 4. Alfa Scientific Designs, Inc.
• 5. Bio-Rad Laboratories, Inc.
• 6. Clinical Reference Laboratory, Inc.
• 7. Cordant Health Solutions
• 8. Danaher Corporation
• 9. Dragerwerk AG & Co. KGaA
• 10. F. Hoffmann-La Roche Ltd.
• 11. Intoximeters, Inc.
• 12. Laboratory Corporation of America Holdings
• 13. Lifeloc Technologies, Inc.
• 14. Merck KGaA
• 15. Omega Laboratories, Inc. by Juno Pharmaceuticals Corp.
• 16. OraSure Technologies, Inc.
• 17. Pfizer Inc.
• 18. Premier Biotech, LLC
• 19. Psychemedics Corporation
• 20. Quest Diagnostics Incorporated
• 21. Sartorius AG
• 22. Securetec Detektions-Systeme AG
• 23. Shimadzu Corporation
• 24. Siemens AG
• 25. Thermo Fisher Scientific Inc.
• 26. United States Drug Testing Laboratories, Inc.